Screener
CorMedix CRMD Change In Contingent Consideration
Change In Contingent Consideration at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept crmd:ChangeInContingentConsideration.
The source filing: CorMedix’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001410098-26-000021
| Line item | For the Three Months Ended March 31, 2026 | For the Three Months Ended March 31, 2025 |
|---|---|---|
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Stock-based compensation | 4,582 | 3,500 |
| Depreciation and amortization | 10,544 | 162 |
| Change in contingent consideration | 4,199 | - |
| Change in fair value of marketable securities | 3,546 | - |
| Deferred income taxes | 12,964 | - |
| Other | 672 | 46 |
| Changes in operating assets and liabilities: |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is CorMedix's change in contingent consideration?
- CorMedix (CRMD) reported change in contingent consideration of -$4.2M in Q1 2026.
- What does change in contingent consideration mean?
- Reflects the periodic adjustment to the estimated fair value of liabilities or assets related to business combinations, such as earn-outs or milestone payments. Changes in this value indicate shifts in management's expectations regarding the achievement of specific performance or regulatory targets. This metric highlights the volatility associated with acquisition-related obligations.
Ask your AI about CorMedix's change in contingent consideration.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude